Mild metabolic acidosis impairs the β-adrenergic response in isolated human failing myocardium

Critical Care

Volumn 16, Issue 4, 2012, Pages

  Schotola, Hanna ^a   Toischer, Karl ^a   Popov, Aron F ^a,b   Renner, André ^c   Schmitto, Jan D ^d   Gummert, Jan ^c   Quintel, Michael ^a   Bauer, Martin ^a   Maier, Lars S ^a   Sossalla, Samuel ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPRENALINE; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

ADRENERGIC SYSTEM; ADULT; ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; HEART FAILURE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE POTENTIAL; HEART MUSCLE RELAXATION; HUMAN; INOTROPISM; MALE; METABOLIC ACIDOSIS; PH; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; ACIDOSIS; DOSE RESPONSE; DRUG EFFECTS; HEART; HEART CONTRACTION; IN VITRO STUDY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

ACIDOSIS; ADRENERGIC BETA-AGONISTS; ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART; HEART FAILURE; HUMANS; HYDROGEN-ION CONCENTRATION; IN VITRO TECHNIQUES; ISOPROTERENOL; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; RECEPTORS, ADRENERGIC, BETA;

EID: 84864815624     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11468     Document Type: Article

References (56)

1. Allen DG, Orchard CH. The effects of changes of pH on intracellular calcium transients in mammalian cardiac muscle. J Physiol 1983, 335:555-567. 1197369, 6410050.
2. Orchard CH, Kentish JC. Effects of changes of pH on the contractile function of cardiac muscle. Am J Physiol 1990, 258:C967-C981.
3. Bers DM, Ellis D. Intracellular calcium and sodium activity in sheep heart Purkinje fibres: effect of changes of external sodium and intracellular pH. Pflugers Arch 1982, 393:171-178. 10.1007/BF00582941, 7099919.
4. Fabiato A, Fabiato F. Effects of pH on the myofilaments and the sarcoplasmic reticulum of skinned cells from cardiace and skeletal muscles. J Physiol 1978, 276:233-255. 1282422, 25957.
5. Kentish JC, Nayler WG. Ca2+-dependent tension generation in chemically 'skinned' cardiac trabeculae: effect of pH [proceedings]. J Physiol 1978, 284:90P-91P.
6. Bers DM. Excitation-Contraction Coupling and Cardiac Contractile Force. 2001, Dordrecht, Netherlands: Kluwer Academic Publishers, 2.
7. Bountra C, Vaughan-Jones RD. Effect of intracellular and extracellular pH on contraction in isolated, mammalian cardiac muscle. J Physiol 1989, 418:163-187. 1189964, 2621616.
8. Donaldson SK, Hermansen L, Bolles L. Differential, direct effects of H+ on Ca2+-activated force of skinned fibers from the soleus, cardiac and adductor magnus muscles of rabbits. Pflugers Arch 1978, 376:55-65. 10.1007/BF00585248, 30066.
9. Lorkovic H. Influence of changes in pH on the mechanical activity of cardiac muscle. Circ Res 1966, 19:711-720. 10.1161/01.RES.19.4.711, 5917846.
10. Morad M, Trautwein W. The effect of the duration of the action potential on contraction in the mammalian heart muscle. Pflugers Arch Gesamte Physiol Menschen Tiere 1968, 299:66-82. 10.1007/BF00362542, 5243673.
11. Kohlhardt M, Wirth K, Dudeck J. [On the influence of metabolic alkalosis and metabolic acidosis on contractility of the isolated heart]. Pflugers Arch Gesamte Physiol Menschen Tiere 1967, 296:352-362. 10.1007/BF00362535, 5239192.
12. Fry CH, Poole-Wilson PA. Effects of acid-base changes on excitation-contraction coupling in guinea-pig and rabbit cardiac ventricular muscle. J Physiol 1981, 313:141-160. 1274441, 7277214.
13. Blanchard EM, Solaro RJ. Inhibition of the activation and troponin calcium binding of dog cardiac myofibrils by acidic pH. Circ Res 1984, 55:382-391. 10.1161/01.RES.55.3.382, 6235979.
14. Choi HS, Trafford AW, Orchard CH, Eisner DA. The effect of acidosis on systolic Ca2+ and sarcoplasmic reticulum calcium content in isolated rat ventricular myocytes. J Physiol 2000, 529(Pt 3):661-668. 2270229, 11118496.
15. Doering AE, Lederer WJ. The mechanism by which cytoplasmic protons inhibit the sodium-calcium exchanger in guinea-pig heart cells. J Physiol 1993, 466:481-499. 1175488, 8410703.
16. Harrison SM, Frampton JE, McCall E, Boyett MR, Orchard CH. Contraction and intracellular Ca2+, Na+, and H+ during acidosis in rat ventricular myocytes. Am J Physiol 1992, 262:C348-C357.
17. Kentish JC, Xiang JZ. Ca(2+)- and caffeine-induced Ca2+ release from the sarcoplasmic reticulum in rat skinned trabeculae: effects of pH and Pi. Cardiovasc Res 1997, 33:314-323. 10.1016/S0008-6363(96)00217-9, 9074695.
18. Philipson KD, Bersohn MM, Nishimoto AY. Effects of pH on Na+-Ca2+ exchange in canine cardiac sarcolemmal vesicles. Circ Res 1982, 50:287-293. 10.1161/01.RES.50.2.287, 7055859.
19. Andersen MN, Border JR, Mouritzen CV. Acidosis, catecholamines and cardiovascular dynamics: when does acidosis require correction?. Ann Surg 1967, 166:344-356. 10.1097/00000658-196709000-00003, 1477429, 6039594.
20. Camilion de Hurtado MC, Argel MI, Cingolani HE. Influence of acid-base alterations on myocardial sensitivity to catecholamines. Naunyn Schmiedebergs Arch Pharmacol 1981, 317:219-224. 10.1007/BF00503820, 6275276.
21. Houle DB, Crisp NW, Weil MH, Brown EB. Depressed response to intravenous sympathicomimetic agents in humans during acidosis. Dis Chest 1958, 33:18-22.
22. Ford GD, Cline WH, Fleming WW. Influence of lactic acidosis on cardiovascular response to sympathomimetic amines. Am J Physiol 1968, 215:1123-1129.
23. Schaer H. Influence of respiratory and metabolic acidosis on epinephrine-inotropic effect in isolated guinea pig atria. Pflugers Arch 1974, 347:297-307. 10.1007/BF00587170, 4859362.
24. Schotola H, Sossalla S, Rajab TK, Toischer K, Quintel M, Bauer M, Schmitto JD. Influence of mild metabolic acidosis on cardiac contractility and isoprenaline response in isolated ovine myocardium. Artif Organs 2011, 35:1065-1074. 10.1111/j.1525-1594.2011.01390.x, 22097981.
25. Litmathe J, Boeken U, Bohlen G, Gursoy D, Sucker C, Feindt P. Systemic inflammatory response syndrome after extracorporeal circulation: a predictive algorithm for the patient at risk. Hellen J Cardiol 2011, 52:493-500.
26. Asimakopoulos G. Systemic inflammation and cardiac surgery: an update. Perfusion 2001, 16:353-360.
27. Nieman G, Searles B, Carney D, McCann U, Schiller H, Lutz C, Finck C, Gatto LA, Hodell M, Picone A. Systemic inflammation induced by cardiopulmonary bypass: a review of pathogenesis and treatment. J Extra Corpor Technol 1999, 31:202-210.
28. Popov AF, Hosseini MT, Zych B, Mohite P, Hards R, Krueger H, Bahrami T, Amrani M, Simon AR. Clinical experience with heartware left ventricular assist device in patients with end-stage heart failure. Ann Thorac Surg 2012, 93:810-815. 10.1016/j.athoracsur.2011.11.076, 22289902.
29. Sossalla S, Fluschnik N, Schotola H, Ort KR, Neef S, Schulte T, Wittkopper K, Renner A, Schmitto JD, Gummert J, El-Armouche A, Hasenfuss G, Maier LS. Inhibition of elevated Ca2+/calmodulin-dependent protein kinase II improves contractility in human failing myocardium. Circ Res 2010, 107:1150-1161. 10.1161/CIRCRESAHA.110.220418, 20814023.
30. Sossalla S, Wagner S, Rasenack EC, Ruff H, Weber SL, Schondube FA, Tirilomis T, Tenderich G, Hasenfuss G, Belardinelli L, Maier LS. Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts: role of late sodium current and intracellular ion accumulation. J Mol Cell Cardiol 2008, 45:32-43. 10.1016/j.yjmcc.2008.03.006, 18439620.
31. Sossalla S, Schotola H, Schmitto J, Toischer K, Sohns C, Schworer H, Hasenfuss G, Maier L, Schillinger W. Effects of different proton pump inhibitors on cardiac contractility in isolated human failing myocardium. J Cardiovasc Surg (Torino) 2011, 52:437-444.
32. Hasenfuss G, Reinecke H, Studer R, Meyer M, Pieske B, Holtz J, Holubarsch C, Posival H, Just H, Drexler H. Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium. Circ Res 1994, 75:434-442. 10.1161/01.RES.75.3.434, 8062417.
33. Solaro RJ, Lee JA, Kentish JC, Allen DG. Effects of acidosis on ventricular muscle from adult and neonatal rats. Circ Res 1988, 63:779-787. 10.1161/01.RES.63.4.779, 3168178.
34. Wakabayashi S, Goshima K. Kinetic studies on sodium-dependent calcium uptake by myocardial cells and neuroblastoma cells in culture. Biochim Biophys Acta 1981, 642:158-172. 10.1016/0005-2736(81)90146-2, 6784764.
35. Hasenfuss G, Schillinger W, Lehnart SE, Preuss M, Pieske B, Maier LS, Prestle J, Minami K, Just H. Relationship between Na+-Ca2+-exchanger protein levels and diastolic function of failing human myocardium. Circulation 1999, 99:641-648. 10.1161/01.CIR.99.5.641, 9950661.
36. Despa S, Islam MA, Weber CR, Pogwizd SM, Bers DM. Intracellular Na(+) concentration is elevated in heart failure but Na/K pump function is unchanged. Circulation 2002, 105:2543-2548. 10.1161/01.CIR.0000016701.85760.97, 12034663.
37. Meyer M, Schillinger W, Pieske B, Holubarsch C, Heilmann C, Posival H, Kuwajima G, Mikoshiba K, Just H, Hasenfuss G. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation 1995, 92:778-784. 10.1161/01.CIR.92.4.778, 7641356.
38. Pieske B, Maier LS, Piacentino V, Weisser J, Hasenfuss G, Houser S. Rate dependence of [Na+]i and contractility in nonfailing and failing human myocardium. Circulation 2002, 106:447-453. 10.1161/01.CIR.0000023042.50192.F4, 12135944.
39. Hasenfuss G, Holubarsch C, Hermann HP, Astheimer K, Pieske B, Just H. Influence of the force-frequency relationship on haemodynamics and left ventricular function in patients with non-failing hearts and in patients with dilated cardiomyopathy. Eur Heart J 1994, 15:164-170.
40. Pieske B, Kretschmann B, Meyer M, Holubarsch C, Weirich J, Posival H, Minami K, Just H, Hasenfuss G. Alterations in intracellular calcium handling associated with the inverse force-frequency relation in human dilated cardiomyopathy. Circulation 1995, 92:1169-1178. 10.1161/01.CIR.92.5.1169, 7648662.
41. Morii I, Kihara Y, Konishi T, Inubushi T, Sasayama S. Mechanism of the negative force-frequency relationship in physiologically intact rat ventricular myocardium: studies by intracellular Ca2+ monitor with indo-1 and by 31P-nuclear magnetic resonance spectroscopy. Jpn Circ J 1996, 60:593-603. 10.1253/jcj.60.593, 8889662.
42. Modest VE, Butterworth JF. Effect of pH and lidocaine on beta-adrenergic receptor binding: interaction during resuscitation?. Chest 1995, 108:1373-1379. 10.1378/chest.108.5.1373, 7587445.
43. Bristow MR, Ginsburg R, Umans V, Fowler M, Minobe W, Rasmussen R, Zera P, Menlove R, Shah P, Jamieson S, Stinson EB. Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. Circ Res 1986, 59:297-309. 10.1161/01.RES.59.3.297, 2876788.
44. Bristow MR, Hershberger RE, Port JD, Gilbert EM, Sandoval A, Rasmussen R, Cates AE, Feldman AM. Beta-adrenergic pathways in nonfailing and failing human ventricular myocardium. Circulation 1990, 82(2 Suppl):I12-25.
45. Perrino C, Rockman HA, Chiariello M. Targeted inhibition of phosphoinositide 3-kinase activity as a novel strategy to normalize beta-adrenergic receptor function in heart failure. Vascul Pharmacol 2006, 45:77-85. 10.1016/j.vph.2006.01.018, 16807128.
46. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med 1982, 307:205-211. 10.1056/NEJM198207223070401, 6283349.
47. Kaplan JA, Guffin AV, Yin A. The effects of metabolic acidosis and alkalosis on the response to sympathomimetic drugs in dogs. J Cardiothorac Anesth 1988, 2:481-487. 10.1016/0888-6296(88)90229-3, 17171933.
48. Felker GM, O'Connor CM. Inotropic therapy for heart failure: an evidence-based approach. Am Heart J 2001, 142:393-401. 10.1067/mhj.2001.117606, 11526351.
49. Felker GM, O'Connor CM. Rational use of inotropic therapy in heart failure. Curr Cardiol Rep 2001, 3:108-113. 10.1007/s11886-001-0035-8, 11177666.
50. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009, 119:e391-479.
51. Dickstein K, Vardas PE, Auricchio A, Daubert JC, Linde C, McMurray J, Ponikowski P, Priori SG, Sutton R, van Veldhuisen DJ, Vahanian A, Bax J, Ceconi C, Dean V, Filippatos G, Funck-Brentano C, Hobbs R, Kearney P, McDonagh T, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas P, Widimsky P, Anker SD, Blanc JJ, Gasparini M, Hoes AW, Israel CW, Kalarus Z, Merkely B, Swedberg K, Camm AJ. 2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy: developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Eur Heart J 2010, 31:2677-2687.
52. Gillies M, Bellomo R, Doolan L, Buxton B. Bench-to-bedside review: inotropic drug therapy after adult cardiac surgery: a systematic literature review. Crit Care 2005, 9:266-279. 10.1186/cc3024, 1175868, 15987381.
53. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36:296-327. 10.1097/01.CCM.0000298158.12101.41, 18158437.
54. Reinhart K, Brunkhorst FM, Bone HG, Bardutzky J, Dempfle CE, Forst H, Gastmeier P, Gerlach H, Grundling M, John S, Kern W, Kreymann G, Kruger W, Kujath P, Marggraf G, Martin J, Mayer K, Meier-Hellmann A, Oppert M, Putensen C, Quintel M, Ragaller M, Rossaint R, Seifert H, Spies C, Stuber F, Weiler N, Weimann A, Werdan K, Welte T. [Prevention, diagnosis, treatment, and follow-up care of sepsis: First revision of the S2k Guidelines of the German Sepsis Society (DSG) and the German Interdisciplinary Association for Intensive and Emergency Care Medicine (DIVI)]. Anaesthesist 2010, 59:347-370. 10.1007/s00101-010-1719-5, 20414762.
55. Bollaert PE, Robin-Lherbier B, Mallie JP, Nace L, Escanye JM, Larcan A. Effects of sodium bicarbonate on striated muscle metabolism and intracellular pH during endotoxic shock. Shock 1994, 1:196-200. 10.1097/00024382-199403000-00007, 7735951.
56. Berger DS, Fellner SK, Robinson KA, Vlasica K, Godoy IE, Shroff SG. Disparate effects of three types of extracellular acidosis on left ventricular function. Am J Physiol 1999, 276:H582-H594.